Neuroleptic discontinuation and tardive dyskinesia risk.
Sherr
J D
JD
Medoff
D
D
Thaker
G
G
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000453:epidemiology; D003430:Cross-Sectional Studies; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D016017:Odds Ratio; D012107:Research Design / Q000592:standards; D012307:Risk Factors; D013375:Substance Withdrawal Syndrome / Q000453:epidemiology / Q000209:etiology*
D014150:Antipsychotic Agents